GX CG5 Pill - brown capsule/oblong, 11mm
Pill with imprint GX CG5 is Brown, Capsule/Oblong and has been identified as Lamivudine 100 mg. It is supplied by Prasco Laboratories.
Lamivudine is used in the treatment of Hepatitis B; Nonoccupational Exposure; HIV Infection; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GX CG5
Lamivudine
- Imprint
- GX CG5
- Strength
- 100 mg
- Color
- Brown
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Prasco Laboratories
- Inactive Ingredients
-
hypromelloses,
polyethylene glycol,
magnesium stearate,
microcrystalline cellulose,
polysorbate 80,
ferric oxide red,
sodium starch glycolate type A potato,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 66993-0478 | Prasco Laboratories |
| 00173-0662 | GlaxoSmithKline |
Related images for "GX CG5"
More about lamivudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
